Rheumnow Podcast Depression and RA (3.8.2024)
Mar 8, 2024
Explore FDA approvals for interchangeable biosimilars and the impact of biologics on Still's disease. Learn about the connection between obstructive sleep apnea and gout, post-SARS-CoV-2 infection risks, and diagnostic utility of MRI in myositis cases. Dive into the role of anti-synthetase antibodies, depression risk in RA patients, and arthritis prevalence in the US.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 3min
Biologics and Still Disease
02:54 • 6min
Exploring the Diagnostic Tools and Antibodies in Myositis Cases
09:10 • 2min
Analysis of Anti-Synthetase Antibodies and Risk Factors in Rheumatology Patients
11:34 • 5min
Impact of Depression on RA Patients and Arthritis Prevalence in the US
16:55 • 3min